Health Catalyst, Inc. reports developments tied to healthcare intelligence, data and analytics technology, and professional services for healthcare organizations. Company updates commonly cover operating results, revenue and Adjusted EBITDA guidance, and the use of AI-driven technology and domain expertise to support health systems across cost, clinical, and consumer performance.
Recurring news also includes leadership and board governance changes, shareholder-related board appointments, investor conference participation, and updates on strategic focus areas for its healthcare data platform, analytics applications, implementation, advisory, outsourcing, and improvement services.
Health Catalyst, Inc. (Nasdaq: HCAT) will announce its fourth quarter and full year 2021 operational results on March 1, 2022, after market close. A conference call will follow at 5 p.m. E.T. that day, providing insights into the company's performance. Interested parties can access the call by calling (877) 295-1104 for U.S. participants or (470) 495-9486 for international attendees. The event will be available via a live audio webcast, with a replay accessible shortly after the call.
Health Catalyst, a leading provider of data and analytics technology in healthcare, announced its participation in the 40th Annual J.P. Morgan Healthcare Conference. Key executives including CEO Dan Burton, CFO Bryan Hunt, and SVP Adam Brown will present on January 11, 2022, at 3:45 p.m. ET. An audio replay will be available on their investor relations website. With a cloud-based platform powered by over 100 million patient records, Health Catalyst aims to drive data-informed healthcare improvements for its clients.
Health Catalyst, a leader in data and analytics for healthcare, will participate in two investor conferences. CFO Bryan Hunt and SVP Adam Brown will represent the company at the Piper Sandler 33rd Annual Healthcare Conference on December 2, 2021, featuring a fireside chat and meetings. On December 1, 2021, they will also attend the Evercore ISI HealthCONx Conference at 3:30 p.m. EST, which includes a fireside chat and one-on-one meetings. Health Catalyst aims to drive data-informed healthcare improvements using its cloud-based platform, enhancing clinical, financial, and operational outcomes.
Health Catalyst, Inc. (HCAT) has announced a strategic partnership with Datavant to enhance research and clinical care through connected health data. This collaboration aims to reduce waste in patient recruitment for clinical trials by using tokenized, de-identified data within the Health Catalyst Research Network™. The partnership will facilitate data connectivity throughout the study life cycle, improving pre-trial feasibility, patient eligibility, and long-term safety analysis. Leaders from both companies emphasize the potential to broaden patient access and improve health outcomes through better data sharing.
Health Catalyst (NASDAQ: HCAT) reported a strong performance for Q3 2021, exceeding revenue and Adjusted EBITDA guidance. Key financial metrics show total revenue of $61.737 million, a 31% year-over-year increase, driven by 37% growth in technology revenue and 22% in professional services. Despite these gains, the company reported a 46% rise in net loss, reaching $40.014 million. Adjusted Technology Gross Profit increased 40% to $26.731 million, reflecting a 70% gross margin. The financial outlook remains cautiously optimistic.
Health Catalyst (Nasdaq: HCAT) will release its 2021 third quarter operating results on November 9, 2021, after market close. A conference call to discuss these results is scheduled for 5 p.m. E.T. the same day. Participants can join the call via phone or through a live audio webcast available on the company's investor relations website. Health Catalyst provides data and analytics technology to healthcare organizations, leveraging a cloud-based platform with data from over 100 million patient records to drive improvements in clinical, financial, and operational outcomes.
Health Catalyst (Nasdaq: HCAT) announced its participation in the Cantor Global Healthcare Conference on September 30, 2021, featuring a fireside chat at 1:20 p.m. ET. The company's CFO, Bryan Hunt, and SVP of Investor Relations, Adam Brown, will represent the organization. Health Catalyst provides data and analytics technology and services aimed at enhancing healthcare performance. Its cloud-based platform leverages data from over 100 million patient records to drive measurable improvements in clinical, financial, and operational areas.
Health Catalyst (Nasdaq: HCAT) announced the addition of Matt Revis to its leadership team, effective August 31, 2021. Revis, previously President and COO of Twistle, will report to COO Paul Horstmeier. He aims to enhance patient engagement technology for better healthcare outcomes. Prior to Twistle, Revis held significant roles at Jibo and Nuance Communications, contributing to product innovation and healthcare strategy. CEO Dan Burton praised Revis's leadership in advancing Health Catalyst's mission of measurable healthcare improvement.
Twistle by Health Catalyst (Nasdaq: HCAT) is enhancing access to obstetric services in Northeastern New Mexico through its partnership with the Rural OB Access & Maternal Services (ROAMS) initiative. This program utilizes Twistle's patient engagement technology to connect patients across five rural communities, allowing direct communication with care teams via mobile devices. The initiative aims to improve maternal health outcomes by reducing barriers such as travel and enhancing monitoring of conditions like gestational diabetes. Twistle's platform is HIPAA-compliant, offering personalized support and education to pre- and post-partum patients.
Health Catalyst has announced a multi-year partnership with Oklahoma Heart Hospital (OHH) aimed at enhancing revenue cycle analytics and performance. The partnership will utilize Health Catalyst's Data Operating System (DOS) platform to improve operational and clinical processes. OHH seeks to drive transparency in care costs and empower clinicians with actionable data. The collaboration is expected to position OHH for ongoing success in a changing healthcare landscape, leveraging Health Catalyst's comprehensive analytics solutions to identify trends and enhance patient care.